| Literature DB >> 26064848 |
Jamshid Abdul-Ghafar1, Yosep Chong1, Hyuck Dong Han2, Dong Soo Cha2, Minseob Eom1.
Abstract
Hyperplasia and neoplasia of mesonephric remnants in the uterine cervix are uncommon conditions that are often mis-diagnosed as usual forms of cervical adenocarcinoma. Here, we report a case of mesonephric adenocarcinoma with florid mesonephric hyperplasia of the uterine cervix in a 48-year-old female patient. The cervix was slightly enlarged eccentrically, without a definite mass-like lesion. Microscopically, the tumor cells infiltrated the cervical stroma with focal myometrial extension and were composed of predominantly round to polygonal cells arranged in ductal, tubular, or cystic structures. The remaining stroma revealed diffuse and florid mesonephric hyperplasia intertwined with tumor cells. Immunohistochemically, the tumor cells were positive for pancytokeratin, epithelial membrane antigen, and CD10. The Ki-67 proliferation index was slightly increased. The patient received routine adjuvant treatment and was alive and clinically free of disease at two-year follow-up.Entities:
Keywords: Adenocarcinoma; Cervix uteri; Hyperplasia; Immunohistochemistry; Mesonephric duct
Year: 2013 PMID: 26064848 PMCID: PMC4390743
Source DB: PubMed Journal: J Lifestyle Med ISSN: 2234-8549
Fig. 1.(A) The stroma shows diffuse florid mesonephric hyperplasia admixed with tumor cells that infiltrated the entire cervical stroma. (B) The tumor is predominantly composed of round to polygonal cells arranged in a ductal, tubular, or cystic pattern.
Fig. 2.Immunohistochemical findings show positive reaction in the tumor cells for (A) epithelial membrane antigen (EMA) and (B) CD10 and negative reaction for (C) CEA. (D) The Ki-67 proliferation index was slightly increased.
Comparative immunohistochemical results of mesonephric adenocarcinoma between the literature and the present case
| Antibodies | Literature [1,5–8] | Present case |
|---|---|---|
| Pancytokeratin | (+) | (+) |
| EMA | (+) | (+) |
| CD10 | (+) & (−) | (+) |
| CEA | (−) | (−) |
| Inhibin | (−) & focal (+) | (−) |
| ER | (−) | (−) |
| PR | (−) | (−) |